The past few years have witnessed tremendous efforts toward the development of promising candidate biomarkers in PC, among them the prognostic significance of TP53 mutation had been proposed (Grochola et al., 2011; Ormanns et al., 2014). This evidence concerns the gene TP53 and pachyonychia congenita.